Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells - PubMed (original) (raw)
. 1997 Dec 1;57(23):5421-5.
Affiliations
- PMID: 9393770
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
B Barleon et al. Cancer Res. 1997.
Abstract
The growth of solid tumors and the formation of metastases are dependent on neoangiogenesis. One of the most important factors in inducing the formation of new blood vessels is the vascular endothelial growth factor (VEGF), which acts specifically on endothelial cells. VEGF is expressed and secreted by almost all solid tumors. The molecular mechanisms leading to enhanced production of this angiogenic mitogen are manyfold and have been elucidated to some degree. Two VEGF receptors, fms-like tyrosine kinase 1 (FLT-1) and KDR, have been identified almost specifically on human endothelial cells. They are expressed preferentially in the proliferating endothelium of vessels lining and/or penetrating solid tumors, whereas they are almost undetectable by convenient methods in vessels of healthy tissue. However, the underlying mechanisms are not understood. We could show that media conditioned by various cancer cell lines grown under hypoxic conditions were able to up-regulate expression of FLT-1 mRNA and protein but not of KDR mRNA. Furthermore, up-regulation of a shorter mRNA species was observed that most probably codes for the soluble variant of FLT-1. These effects were completely inhibited by VEGF-neutralizing extracellular VEGF receptor domains. The effect could be mimicked by adding recombinant VEGF instead of conditioned cancer cell medium to the endothelial cell cultures. Both mutant VEGF, which activates only KDR, and placenta growth factor, which activates only FLT-1, were able to enhance FLT-1 expression. VEGF-stimulated FLT-1 mRNA expression was inhibited by actinomycin D. These data suggest that VEGF itself is the main factor secreted by tumor cells that is able to enhance the expression of its receptor FLT-1 and of a soluble variant of FLT-1 in endothelial cells.
Similar articles
- Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
Takagi H, King GL, Ferrara N, Aiello LP. Takagi H, et al. Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1311-21. Invest Ophthalmol Vis Sci. 1996. PMID: 8641834 - Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S. Shibuya M, et al. Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review. - Vascular endothelial growth factor: possible role in fetal development and placental function.
Cheung CY. Cheung CY. J Soc Gynecol Investig. 1997 Jul-Aug;4(4):169-77. J Soc Gynecol Investig. 1997. PMID: 9292845 Review.
Cited by
- Regression of Human Breast Carcinoma in Nude Mice after Ad_sflt_ Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis.
Felici A, Bottaro DP, Mangoni A, Reusch P, Marmé D, Kovesdi I, De Silva DM, Lee YH, Capogrossi MC, Mühlhauser J. Felici A, et al. Cancers (Basel). 2022 Dec 14;14(24):6175. doi: 10.3390/cancers14246175. Cancers (Basel). 2022. PMID: 36551660 Free PMC article. - Maternal nutrient restriction and over-feeding during gestation alter expression of key factors involved in placental development and vascularization.
Reed SA, Ashley R, Silver G, Splaine C, Jones AK, Pillai SM, Peterson ML, Zinn SA, Govoni KE. Reed SA, et al. J Anim Sci. 2022 Jun 1;100(6):skac155. doi: 10.1093/jas/skac155. J Anim Sci. 2022. PMID: 35648126 Free PMC article. - Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H, Marahleh A, Ohori F, Noguchi T, Shen WR, Qi J, Nara Y, Pramusita A, Kinjo R, Mizoguchi I. Kitaura H, et al. Int J Mol Sci. 2020 Jul 21;21(14):5169. doi: 10.3390/ijms21145169. Int J Mol Sci. 2020. PMID: 32708317 Free PMC article. Review. - VEGFA From Early Osteoblast Lineage Cells (Osterix+) Is Required in Mice for Fracture Healing.
Buettmann EG, McKenzie JA, Migotsky N, Sykes DA, Hu P, Yoneda S, Silva MJ. Buettmann EG, et al. J Bone Miner Res. 2019 Sep;34(9):1690-1706. doi: 10.1002/jbmr.3755. Epub 2019 Aug 1. J Bone Miner Res. 2019. PMID: 31081125 Free PMC article. - CXCR4 signaling at the ovine fetal-maternal interface regulates vascularization, CD34+ cell presence, and autophagy in the endometrium†.
Runyan CL, McIntosh SZ, Maestas MM, Quinn KE, Boren BP, Ashley RL. Runyan CL, et al. Biol Reprod. 2019 Jul 1;101(1):102-111. doi: 10.1093/biolre/ioz073. Biol Reprod. 2019. PMID: 31004477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous